DGAP-Adhoc: SYGNIS AG plans to issue new shares to finance

SYGNIS AG / Key word(s): Capital Increase 17.11.2015 12:09 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc announcement according to § 15 WpHG --------------------------------------------------------------------------- NOT FOR DISTRIBUTION, PUBLICATION, OR TRANSMISSION IN USA, CANADA, JAPAN AND AUSTRALIA SYGNIS AG plans to issue new shares to finance further growth and commercialization of proprietary product Portfolio - Cash capital increase by way of a rights offering of up to 3,855,694 new shares and targeted gross proceeds of EUR 6.7 million - Subscription price per new share is EUR 1.90 - Proceeds used to progress the product portfolio, commercialization of the product pipeline and expansion of customer base worldwide and other purposes - Major shareholder Genetrix S.L., Spain, committed to contribute EUR 600,000 in kind by swapping its shareholder loan into equity Madrid, Spain and Heidelberg, Germany, November 17, 2015 - SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today resolved, with the approval of the Supervisory Board, to increase the Company's share capital by up to EUR 3.9 million by issuing up to 3,855,694 new shares in order to finance the expansion of its commercialization activities, especially to the US, among other things. To this end, the Company is planning a cash capital increase by way of a rights offering for existing shareholders. A total of up to approx. 3.9 million new shares will be offered for subscription. An oversubscription is possible. Any new shares not subscribed for will be offered for sale to selected qualified investors in private placements. The Management Board and Supervisory Board of SYGNIS AG today resolved that a tranche of these new shares, valued at approx. EUR 600,000 will be issued as a capital increase against contributions in Kind in order to swap a substantial portion of an existing loan from major shareholder Genetrix S.L., Spain, into equity. Capital increase by way of a rights offering and against contributions in kind: SYGNIS AG intends to increase its share capital from EUR 13,494,934.00 composed of 13,494,934 no-par value bearer shares, to up to EUR 17,350,628.00, composed of up to 17,350,628 shares, while partially utilising authorized capital. With the rights issue, the share capital of the Company will be increased by up to EUR 3,855,694.00 in return for cash contributions and contributions in kind by up to 3,855,694 new no-par value bearer shares, each with a notional par value of EUR 1.00. The new shares (Offer Shares) will be offered to existing shareholders through indirect pre-emptive rights by Small & Mid Cap Investmentbank AG (Munich, Germany). The subscription ratio is 7:2, thus seven existing shares entitle the holder to subscribe for two new shares. An oversubscription is possible. There shall be no organized trading in subscription rights. The subscription price per new share is EUR 1.90. Any new shares not subscribed in the offering will be offered for sale in private placements to selected qualified investors after the end of the subscription period. The Company aims to generate gross proceeds of EUR 6.7 million from the cash capital increase, not including the EUR 0.6 million loan contribution. Generated proceeds will be used to progress the product portfolio, for further commercialization of the existing products, and to grow and expand the customer base worldwide, particularly in the US. For further details on the rights issue, please see the subscription offer provisionally planned to be published in the electronic Federal Gazette on 20 November 2015 and on the website of SYGNIS AG (www.sygnis.com). The securities prospectus will be published under www.sygnis.com/investors. **** End of ad hoc announcement **** For further information please contact: SYGNIS AG MC Services AG Pilar de la Huerta Raimund Gabriel CEO/CFO Managing Partner Phone: +34 91 192 36 50 Phone: +49 89 210228 30 Email: pdelahuerta@sygnis.com Email: raimund.gabriel@mc-services.eu About SYGNIS AG: www.sygnis.com SYGNIS, headquartered in Germany and Spain, specializes on the development and commercialization of innovative products for DNA amplification and sequencing. Based on its proprietary technologies, SYGNIS has developed a commercial product portfolio addressing key challenges in the fast growing fields of molecular biology and next generation sequencing applications. Key products include the TruePrime(TM) product line and SensiPhi(R), licensed to an industry leading partner, for whole genome DNA amplification and sequencing as well as the SunScript(TM) Reverse Transcriptase product family to convert genetic information from RNA molecules back to DNA. SYGNIS AG is listed at the German Stock Exchange in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03). ### This document is not a securities prospectus and the information contained therein does not constitute an offer to sell or a solicitation of an offer to purchase any securities of SYGNIS AG in Federal Republic of Germany nor under any other jurisdiction, in particular not where such kind of offer or solicitation is prohibited or lacks the required permission. Potential investors in securities of SYGNIS AG are asked to familiarize themselves with and to observe the respective restrictions. A decision to invest in the securities of SYGNIS AG should only be made on the basis of the securities prospectus detailing the public offering of securities of SYGNIS AG in the Federal Republic of Germany, which, subject to the approval of the German Federal Financial Supervisory Authority (BaFin) is anticipated to be published under www.sygnis.com/investors. The information in this document may not be disseminated outside the Federal Republic of Germany in particular not in the United States, to US Persons (as defined in regulation S of the US Securities Act of 1933) or to publications with a general circulation in the United States with the exception of a such disclosures or announcements outside the Federal Republic of Germany which have to be made under the respective mandatory law. Any person who fails to comply with these restrictions may violate the security laws of certain jurisdictions, in particular of the United States. Securities in SYGNIS AG are not publicly offered outside the Federal Republic of Germany. ### 17.11.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: SYGNIS AG Waldhofer Str. 104 69123 Heidelberg Germany Phone: +49 (0) 6221 3540 125 Fax: +49 (0) 6221 3540 127 E-mail: investors@sygnis.com Internet: www.sygnis.com ISIN: DE000A1RFM03 WKN: A1RFM0 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------